國立高雄大學圖資館 |

Language: English

Back

Cancer policypharmaceutical safety /

McKoy, June M.

Cancer policypharmaceutical safety /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Cancer policyedited by June M. McKoy, Dennis P. West.
Reminder of title:	pharmaceutical safety /
other author:	McKoy, June M.
Published:	Cham :Springer International Publishing :2019.
Description:	v, 128 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
Subject:	DrugsSafety measures.
Online resource:	https://doi.org/10.1007/978-3-319-43896-2
ISBN:	9783319438962$q(electronic bk.)

Cancer policypharmaceutical safety /
Cancer policypharmaceutical safety /[electronic resource] :edited by June M. McKoy, Dennis P. West. - Cham :Springer International Publishing :2019. - v, 128 p. :ill., digital ;24 cm. - Cancer treatment and research,v.1710927-3042 ;. - Cancer treatment and research ;v. 114..

Pharmacovigilance programs: Do they improve Cancer Drug Safety? -- Impact of Cost on the Safety of Cancer pharmaceuticals -- Assessing pharmaceutical safety in Geriatric Oncology -- Cancer co-Morbidity: Implications for Drug Safety -- Statistical aids to signal generation: Are they effective in Identifying Adverse Cancer Drug Reactions? -- Pharmacovigilance of alternative medications in the Cancer Setting -- Key elements in Adverse Drug Interaction Safety Signals: evaluation of individual case reports in oncology -- Biosimilars: Are they really safe? -- Natural Language processing: improving the identification and communication of Cancer Drug Safety -- The Drug Shortage Crisis in the United States: Impact on cancer pharmaceutical safety -- Anatomy of Risk Evaluation and Mitigation Strategies (REMS) -- Cancer Drug Toxicity: Moving from patient to Survivor.

Cancer Policy: Pharmaceutical Safety provides invaluable information on the interesting and compelling field of cancer drug safety. Identifying and understanding high-priority policy issues and key pharmacovigilance strategies is of paramount importance. In this volume, outstanding and original chapters provide an overview and synthesis of the latest thoughts and findings relating to drug safety in the cancer domain. Topics include natural language processing and pharmacovigilance of alternative cancer pharmaceuticals. The information presented in this volume will improve understanding of emerging strategies to identify adverse drug reactions and drug-drug interactions within the cancer setting and will highlight policies that have been instituted to improve cancer patient safety. In summary, Cancer Policy: Pharmaceutical Safety explores many of the important areas of pharmacovigilance research in oncology.

ISBN: 9783319438962$q(electronic bk.)

Standard No.: 10.1007/978-3-319-43896-2doiSubjects--Topical Terms:

302362
Drugs
--Safety measures.

LC Class. No.: RM301.15

Dewey Class. No.: 615.1

Cancer policypharmaceutical safety /
LDR:02803nmm a2200337 a 4500 001 555878
003 DE-He213
005 20190715172143.0
006 m d
007 cr nn 008maaau
008 191121s2019 gw s 0 eng d
020 $a 9783319438962$q(electronic bk.)
020 $a 9783319438948$q(paper)
024 7 $a 10.1007/978-3-319-43896-2 $2 doi
035 $a 978-3-319-43896-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RM301.15
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 615.1 $2 23
090 $a RM301.15 $b .C215 2019
245 0 0 $a Cancer policy $h [electronic resource] : $b pharmaceutical safety / $c edited by June M. McKoy, Dennis P. West.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a v, 128 p. : $b ill., digital ; $c 24 cm.
490 1 $a Cancer treatment and research, $x 0927-3042 ; $v v.171
505 0 $a Pharmacovigilance programs: Do they improve Cancer Drug Safety? -- Impact of Cost on the Safety of Cancer pharmaceuticals -- Assessing pharmaceutical safety in Geriatric Oncology -- Cancer co-Morbidity: Implications for Drug Safety -- Statistical aids to signal generation: Are they effective in Identifying Adverse Cancer Drug Reactions? -- Pharmacovigilance of alternative medications in the Cancer Setting -- Key elements in Adverse Drug Interaction Safety Signals: evaluation of individual case reports in oncology -- Biosimilars: Are they really safe? -- Natural Language processing: improving the identification and communication of Cancer Drug Safety -- The Drug Shortage Crisis in the United States: Impact on cancer pharmaceutical safety -- Anatomy of Risk Evaluation and Mitigation Strategies (REMS) -- Cancer Drug Toxicity: Moving from patient to Survivor.
520 $a Cancer Policy: Pharmaceutical Safety provides invaluable information on the interesting and compelling field of cancer drug safety. Identifying and understanding high-priority policy issues and key pharmacovigilance strategies is of paramount importance. In this volume, outstanding and original chapters provide an overview and synthesis of the latest thoughts and findings relating to drug safety in the cancer domain. Topics include natural language processing and pharmacovigilance of alternative cancer pharmaceuticals. The information presented in this volume will improve understanding of emerging strategies to identify adverse drug reactions and drug-drug interactions within the cancer setting and will highlight policies that have been instituted to improve cancer patient safety. In summary, Cancer Policy: Pharmaceutical Safety explores many of the important areas of pharmacovigilance research in oncology.
650 0 $a Drugs $x Safety measures. $3 302362
650 0 $a Cancer $x Treatment. $3 252269
650 0 $a Pharmaceutical industry. $3 188828
650 0 $a Pharmaceutical policy. $3 323280
650 1 4 $a Oncology. $3 195181
650 2 4 $a Drug Safety and Pharmacovigilance. $3 701740
700 1 $a McKoy, June M. $3 838213
700 1 $a West, Dennis P. $3 838214
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Cancer treatment and research ; $v v. 114. $3 452091
856 4 0 $u https://doi.org/10.1007/978-3-319-43896-2
950 $a Medicine (Springer-11650)